Herein, we provide the first evidence of CCL5-inducible signalling events in breast cancer cells, mediated by CCR5, that regulate metabolic activity to support enhanced cell proliferation, migration and invasion facilitating tumour progression. The gene discussed is CCL5; the disease is neoplasm.